Literature DB >> 33093048

Complete Genome Sequence of Burkholderia cenocepacia K56-2, an Opportunistic Pathogen.

Inmaculada García-Romero1, Miguel A Valvano2.   

Abstract

Burkholderia cenocepacia K56-2, an opportunistic bacterium for people with cystic fibrosis (CF), belongs to the Burkholderia cepacia complex (Bcc) and is consistently used as a model pathogen. We describe here the closed genome sequence for this strain, which will help advance research in B. cenocepacia biology and omics studies.
Copyright © 2020 García-Romero and Valvano.

Entities:  

Year:  2020        PMID: 33093048      PMCID: PMC7585848          DOI: 10.1128/MRA.01015-20

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

The Burkholderia cepacia complex (Bcc) comprises a set of Burkholderia species that cause respiratory infection in people with cystic fibrosis (CF) (1 – 3). These bacteria are multidrug-opportunistic intracellular pathogens (reviewed in reference 1). B. cenocepacia, in particular, can be transmissible (4) and causes a fatal condition known as cepacia syndrome (5, 6). In this whole-genome sequencing (WGS) project, we have closed the genome sequence of B. cenocepacia K56-2, which belongs to the ET-12 lineage and was isolated from a CF patient in Canada (2, 3). The strain used in this study was isolated as described in reference 3. To date, no complete genome sequence for K56-2 has been deposited into GenBank; a draft genome containing 19 contigs was published in 2013 (7). In this work, the genome sequence was assembled de novo. Strain K56-2 was grown in 25 ml LB (Melford) at 37°C and 180 rpm to an optical density (600 nm) of 0.6. Pelleted bacteria (4,000 × g for 10 min) were resuspended in a cryopreservative (Microbank; Pro-Lab Diagnostics UK, United Kingdom) and shipped to MicrobesNG (Birmingham, United Kingdom). Two different sequencing approaches were used, Illumina HiSeq technology (a 250-bp paired-end protocol) and a GridION system using a FLO-MIN-106 (R.9.4) flow cell (ONT, United Kingdom). For the former, genomic DNA was purified using a QIAamp DNA minikit (Qiagen, Germany). For the latter, high-molecular-weight genomic DNA was extracted using a Nanobind CCB Big DNA kit (Circulomics, MD, USA). Libraries for Illumina sequencing were prepared using the Nextera XT library prep kit (Illumina, San Diego, USA) according to the manufacturer’s protocol. Long-read genomic DNA libraries for GridION sequencing were prepared with the Oxford Nanopore SQK-RBK004 kit (ONT) using 500 ng of high-molecular-weight DNA and in accordance with MicrobesNG protocols (https://microbesng.com/documents/5/MicrobesNG_Methods_Document_-_PDF.pdf). For Nanopore reads, base calling was performed using Guppy v3.0.6+9999d81 (8), generating 29,635 long reads with an N 50 value of 7,943 bp. Illumina reads were adapter trimmed using Trimmomatic 0.30 with a sliding window quality cutoff of Q15 (9), resulting in 1,734,906 reads of 250 bp. Illumina and Nanopore reads were coassembled using Unicycler v0.4.0 (10), obtaining a final assembly of 4 replicons (with a genome coverage of 107.62×). Default parameters were used for all software unless otherwise specified. The complete genome sequence of strain K56-2 consists of 3 circular chromosomes of 3,673,077 bp (GC content of 66.89%), 3,211,025 bp (GC content of 67.29%), and 765,157 bp (GC content of 66.92%) and a plasmid of 92,661 bp (GC content of 62.76%). The smaller replicon was defined as a plasmid due to the absence of rRNAs and tRNAs and the high similarity (99.9% identity) with pBCJ2315 (NC_011003). All the replicons were manually rotated to match those in the B. cenocepacia J2315 genome (11). Functional annotation was performed using Prokka 1.12 (12), with a cutoff E value of 1e−05 for coding DNA sequence (CDS) annotation plus adding the noncoding RNA (ncRNA) annotation step using Infernal software v1.1.3 (13) and the Rfam database (14). According to the automatic annotation, the K56-2 genome comprises 7,121 genes, with 6,973 protein-encoding genes, 82 tRNAs, 18 rRNAs, and 48 noncoding RNAs (Table 1).
TABLE 1

Main features of K56-2 genome annotation

RepliconLocus tagANa No. of:
GenesProteinsrRNAstRNAsncRNAs
Chr 1K562_1 CP053300 3,4533,3371267b 37
Chr 2K562_2 CP053301 2,9022,8803118
Chr 3K562_3 CP053302 660651342
PlasmidK562_4 CP053303 106105 1
Total 7,1216,973188248

GenBank accession number.

Including a transfer-messenger RNA (tmRNA).

Main features of K56-2 genome annotation GenBank accession number. Including a transfer-messenger RNA (tmRNA).

Data availability.

The genome sequence of strain K56-2 was deposited in GenBank under the accession numbers indicated in Table 1. The raw sequence reads were deposited in the SRA under the accession numbers SRR11609092 (GridION) and SRR11609093 (Illumina HiSeq 2500). The associated BioProject and BioSample accession numbers are PRJNA627986 and SAMN14693155, respectively.
  14 in total

1.  Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients.

Authors:  Benjamin T Kopp; Basant A Abdulrahman; Arwa A Khweek; Surender B Kumar; Anwari Akhter; Richard Montione; Mia F Tazi; Kyle Caution; Karen McCoy; Amal O Amer
Journal:  Biochem Biophys Res Commun       Date:  2012-06-20       Impact factor: 3.575

2.  Intracellular survival of Burkholderia cepacia complex in phagocytic cells.

Authors:  Miguel A Valvano
Journal:  Can J Microbiol       Date:  2015-06-30       Impact factor: 2.419

3.  Studying RNA Homology and Conservation with Infernal: From Single Sequences to RNA Families.

Authors:  Lars Barquist; Sarah W Burge; Paul P Gardner
Journal:  Curr Protoc Bioinformatics       Date:  2016-06-20

4.  Burkholderia cenocepacia ET12 transmission in adults with cystic fibrosis.

Authors:  Ana C Blanchard; Lin Tang; Manal Tadros; Matthew Muller; Theodore Spilker; Valerie J Waters; John J LiPuma; Elizabeth Tullis
Journal:  Thorax       Date:  2019-11-15       Impact factor: 9.139

5.  Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.

Authors:  P Darling; M Chan; A D Cox; P A Sokol
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

7.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

8.  Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads.

Authors:  Ryan R Wick; Louise M Judd; Claire L Gorrie; Kathryn E Holt
Journal:  PLoS Comput Biol       Date:  2017-06-08       Impact factor: 4.475

9.  Performance of neural network basecalling tools for Oxford Nanopore sequencing.

Authors:  Ryan R Wick; Louise M Judd; Kathryn E Holt
Journal:  Genome Biol       Date:  2019-06-24       Impact factor: 13.583

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more
  2 in total

1.  Protein with negative surface charge distribution, Bnr1, shows characteristics of a DNA-mimic protein and may be involved in the adaptation of Burkholderia cenocepacia.

Authors:  Ruth Dennehy; Niamh Duggan; Simon Dignam; Sarah McCormack; Eugene Dillon; Jessica Molony; Maria Romano; Yueran Hou; Laura Ardill; Matthew V X Whelan; Zuzanna Drulis-Kawa; Tadhg Ó'Cróinín; Miguel A Valvano; Rita Berisio; Siobhán McClean
Journal:  Microbiologyopen       Date:  2022-02       Impact factor: 3.904

Review 2.  The Use of Artificial Sputum Media to Enhance Investigation and Subsequent Treatment of Cystic Fibrosis Bacterial Infections.

Authors:  Aditi Aiyer; Jim Manos
Journal:  Microorganisms       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.